Soligenix, Inc. (SNGX)
NASDAQ: SNGX · IEX Real-Time Price · USD
6.07
-0.32 (-5.01%)
At close: Jul 19, 2024, 4:00 PM
6.00
-0.07 (-1.15%)
Pre-market: Jul 22, 2024, 7:38 AM EDT
Soligenix Revenue
Soligenix had revenue of $699.21K in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $117.03K. In the year 2023, Soligenix had annual revenue of $839.36K.
Revenue (ttm)
$699.21K
Revenue Growth
-31.32%
P/S Ratio
8.57
Revenue / Employee
$46,614
Employees
15
Market Cap
5.99M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 839.36K | -109.55K | -11.55% |
Dec 31, 2022 | 948.91K | 124.64K | 15.12% |
Dec 31, 2021 | 824.27K | -1.54M | -65.07% |
Dec 31, 2020 | 2.36M | -2.27M | -49.04% |
Dec 31, 2019 | 4.63M | -611.53K | -11.67% |
Dec 31, 2018 | 5.24M | -191.02K | -3.52% |
Dec 31, 2017 | 5.43M | -5.02M | -48.01% |
Dec 31, 2016 | 10.45M | 1.68M | 19.16% |
Dec 31, 2015 | 8.77M | 1.73M | 24.50% |
Dec 31, 2014 | 7.04M | 3.82M | 118.45% |
Dec 31, 2013 | 3.22M | 79.53K | 2.53% |
Dec 31, 2012 | 3.14M | -4.52M | -58.96% |
Dec 31, 2011 | 7.66M | 5.72M | 293.44% |
Dec 31, 2010 | 1.95M | -868.41K | -30.84% |
Dec 31, 2009 | 2.82M | 505.77K | 21.89% |
Dec 31, 2008 | 2.31M | 1.05M | 83.64% |
Dec 31, 2007 | 1.26M | -1.06M | -45.61% |
Dec 31, 2006 | 2.31M | -762.72K | -24.80% |
Dec 31, 2005 | 3.08M | 2.08M | 208.35% |
Dec 31, 2004 | 997.48K | 913.67K | 1,090.07% |
Dec 31, 2003 | 83.82K | - | - |
Dec 31, 2002 | 0 | - | - |
Dec 31, 2001 | 0 | - | - |
Dec 31, 2000 | 0 | - | - |
Dec 31, 1999 | 0 | - | - |
Dec 31, 1998 | 0 | - | - |
Dec 31, 1997 | 0 | - | - |
Dec 31, 1996 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CareMax | 810.36M |
SunLink Health Systems | 35.51M |
Sonoma Pharmaceuticals | 12.74M |
ReShape Lifesciences | 8.34M |
TFF Pharmaceuticals | 885.72K |
Titan Pharmaceuticals | 87.00K |
SNGX News
- 6 days ago - PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results - GlobeNewsWire
- 12 days ago - Soligenix stock rallies 400% on positive HyBryte trial results - Invezz
- 12 days ago - Crude Oil Down 1%; Soligenix Shares Surge - Benzinga
- 12 days ago - Nano-Cap Soligenix Stock Surges Over 200% On Tuesday, Here's Why - Benzinga
- 13 days ago - Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma - PRNewsWire
- 27 days ago - Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma - PRNewsWire
- 5 weeks ago - A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference - PRNewsWire
- 6 weeks ago - Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire